FDA approved Novo Nordisk’s Wegovy for MASH Treatment

The U.S. Food and Drug Administration (FDA) has approved GSK’s biologic therapy, Nucala (mepolizumab), as an add-on maintenance treatment...

Top 10 pharmaceutical companies by revenues (H1 2025) TOP PHARMACEUTICAL COMPANIES BY REVENUES 2025 Rank Company Q1 H1 9M Annual 1...

Most Anticipated New Drug Launches of 2025 The pharmaceutical industry is set for another groundbreaking year in 2025, with several...

Novartis has announced plans to acquire Anthos Therapeutics, a biopharmaceutical company specializing in cardiovascular treatments, for...

Top selling drugs of 2024 Sl No Brand Q1 Revenues 1 Keytruda $29.5 billion 2 Ozempic $16.7 billion 3 Dupixent $13.4 billion 4 Eliquis $...

AstraZeneca and Daiichi Sankyo have announced that the U.S. Food and Drug Administration (FDA) has approved Enhertu (trastuzumab...

CHMP gave a positive opinion for treating BMS' cell-therapy Breyanzi for relapsed or refractory follicular lymphoma Bristol Myers Squibb...

TOP PHARMACEUTICAL COMPANIES BY REVENUES IN 2024 Sl No Company Q1 Q2 Q3 Total Best selling products 1 JOHNSON AND JOHNSON $21.8 $43.8...

Roche has announced that its investigational drug, Itovebi (inavolisib), in combination with palbociclib and fulvestrant, has...

Pfizer's Targeted Therapy Shows Promising Results for Metastatic Colorectal Cancer with BRAF V600E Mutation Pfizer has shared positive...

Sanofi announced that Sarclisa (isatuximab) has been approved by the European Union (EU) for use in combination with the standard-of-care...

Novo Nordisk has announced promising results from its STEP UP phase 3b trial, revealing that a 7.2 mg dose of semaglutide administered...

In a strategic move to advance cancer therapeutics, AbbVie and Simcere Zaiming, a subsidiary of Simcere Pharmaceutical Group, have...

Eli Lilly has announced that the U.S. Food and Drug Administration (FDA) has granted approval for Omvoh (mirikizumab) as a treatment for...